# Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

> **NCT06005649** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Juventas Cell Therapy Ltd.**

## Conditions studied

- Non-hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** HY004

## Key facts

- **NCT ID:** NCT06005649
- **Lead sponsor:** Juventas Cell Therapy Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-09
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor changed product development plan
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005649, "Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06005649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*